Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,000
Closed -$13K 6066
2020
Q1
$13K Hold
1,000
﹤0.01% 5758
2019
Q4
$14K Buy
+1,000
New +$14.6K ﹤0.01% 6049
2019
Q1
Sell
-600
Closed -$7K 7236
2018
Q4
$7K Hold
600
﹤0.01% 6338
2018
Q3
$15K Sell
600
-500
-45% -$11.2K ﹤0.01% 6548
2018
Q2
$20K Sell
1,100
-700
-39% -$12.1K ﹤0.01% 6194
2018
Q1
$20K Buy
+1,800
New +$25.3K ﹤0.01% 6437
2017
Q3
Sell
-4,000
Closed -$80K 6988
2017
Q2
$80K Sell
4,000
-177,500
-98% -$3.1M ﹤0.01% 5073
2017
Q1
$2.74M Buy
+181,500
New +$1.99M ﹤0.01% 1782

Other funds holding OMER

Barclays's OMER Position: Q2 2026 in Review

Barclays increased its Omeros (OMER) stake by 5% in Q2 2026, buying an estimated $26.6K and bringing the position to 47,157 shares worth $448K. The position accounts for ﹤0.01% of the portfolio, ranked #3288.

Barclays first reported a position in OMER in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.07M in Q4 2025. 171 funds tracked by Wall St. Rank hold OMER as of Q2 2026.

  • Barclays held 47,157 shares of Omeros worth $448K as of Q2 2026.
  • Barclays bought 2,235 Omeros shares in Q2 2026, an estimated $26.6K.
  • Omeros made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3288 holding.
  • Barclays first reported a position in Omeros in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Omeros position peaked at $2.07M in Q4 2025.
  • 171 funds tracked by Wall St. Rank held Omeros as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.